Pharmaceutical Technology Europe
An environmental risk assessment (ERA) is now required for all new pharmaceutical product marketing authorisation applications. The author outlines the steps to this procedure.
D.F. de Roode
Advertisement
D.F. de Roode is Regulatory Affairs Manager at NOTOX B.V. Tel. +31(0)73 640 67 00 Fax: +31(0)73 640 67 99 Email: [email protected]
Articles by D.F. de Roode
Advertisement
Latest Updated Articles
- Assessing environmental risk of pharmaceuticals
June 1st 2010
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Duloxetine Recall Highlights Generic Manufacturing Quality Gaps
2
Germany Pharma Tariff Threat: What Manufacturers Need to Know
3
Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next
4
PharmTech Weekly Roundup—June 19, 2026
5